Phase Ⅰa Clinical Study of Hawthorn Red Pigment Combined With Standard Analgesic for Refractory Cancer Pain
Condition: Hawthorn Red Combined Refractory Cancer Pain Intervention: Drug: Hawthorn red pigment Sponsor: Fujian Cancer Hospital Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials